NERV Q2 2020 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$53M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M

Gross Profit

$41M100.0% margin

Operating Income

$30M71.7% margin

Net Income

$30M71.7% margin

EPS (Diluted)

$5.84

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$66M

Total Liabilities

$9M

Stockholders' Equity

$57M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$0	—
Gross Profit	$41M	$0	—
Operating Income	$30M	-$13M	+328.7%
Net Income	$30M	-$12M	+336.7%